FGF2 and urinary bladder cancer: A possible explanation for poor prognosis of FGF-2 expressing bladder cancers is the association with epithelial to mesenchymal transition (EMT), high proliferation, low mutation load and high expression of CTLA-4, PD-1 and PD-L1, thus being more sensitive to immune checkpoint inhibition [46].